REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/01/2025
Back to search
Official data from USPTO
BIOEPIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
11/02/2025
Trademark type
Word
Nice classes
5, 42
Filing date
10/13/2015
Registration date
11/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/25/2023
Last transaction
11/02/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Incheon, KR
Examiner
CROWLEY,SEAN MICHAEL
Law office
M70
Current location
TMO LAW OFFICE 116
Holders and representatives
Holders
Samsung Bioepis Co., LTD.
Representatives
Stephen R. Barrese Dilworth & Barrese Llp
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Preparations for medical usepreparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for treatment of immunologic disordersfor immunoregulationfor treatment of autoimmune diseasesfor treatment of inflammatory diseasesfor treatment of arthritisfor Anti-cancer agentsfor treatment of cancerfor treatment of tumorfor treatment of central nervous system disorders and for treatment of metabolic diseases; Preparations for treatment of immunologic disorders; Preparations for immunoregulation; Preparations for treatment of autoimmune diseases; Preparations for treatment of inflammatory diseases; Preparations for treatment of arthritis; Anti-cancer agents; Preparations for treatment of cancer; Preparations for treatment of tumor; Preparations for diagnosis for medical purposes; Preparations for treatment of central nervous system disorders; Preparations for treatment of metabolic diseases; Biological tissue cultures for medical purposes
Class 42
Pharmaceutical research and development; Bacteriological research; Biological research; Biotechnology research; Biopharmaceutical research and development; Medical product testing; Research and development for new products for others; Material testing; Chemistry serviceschemistry consultation; Chemical research and analysis; Biotechnology consultation; Pharmaceutical development using animal cells; Scientific technology research relating to plant genetics; Laboratory equipment rental
Publications
History of USPTO decisions and trademark events.
35 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/25/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/25/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/25/2023
E815
TEAS SECTION 8 & 15 RECEIVED
04/27/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/01/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/29/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/21/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2016
PUBO
PUBLISHED FOR OPPOSITION
09/06/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/17/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/03/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/24/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/24/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/23/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/06/2016
GNSL
LETTER OF SUSPENSION E-MAILED
04/06/2016
CNSL
SUSPENSION LETTER WRITTEN
04/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2016
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/20/2016
GPRA
PRIORITY ACTION E-MAILED
01/20/2016
CPRA
PRIORITY ACTION WRITTEN
01/20/2016
DOCK
ASSIGNED TO EXAMINER
01/14/2016
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/20/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/17/2015
ALIE
ASSIGNED TO LIE
11/16/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/27/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/19/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2015
NWAP
NEW APPLICATION ENTERED
10/16/2015
Continuous trademark protection
Get notified about every new filing that threatens BIOEPIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.